A new special section entitled, “Nanotechnology Based Delivery Strategies for Protein and Peptide Therapeutics” is now available in the January 2024 issue of The Journal of Pharmacology and Experimental Therapeutics. It highlights the significance of protein and peptide-based therapeutics in multiple disorders along with offering a deeper understanding of the delivery challenges associated with these macromolecules creating barriers towards their clinical translation.

This collection of papers includes five systematic reviews from experts on advanced strategies for the effective delivery of proteins and peptides. It also offers a deep understanding on the barriers to the clinical translation of protein and peptide therapeutics. In addition, it presents an exhaustive compilation of different promising strategies to improve stability, bioavailability, impart targeting ability and controlled release to deliver these in cancer, diabetes, infectious and inflammatory disorders.

All content in this special section is freely accessible through June 2024.